Nesivine (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nesivine, is an alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis. GNH USA supplies Nesivine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nesivine, an alpha‑adrenergic agonist, is used to alleviate congestion in the upper respiratory tract. - Common cold: reduces nasal blockage and improves airflow. - Sinusitis: eases sinus‑related congestion and pressure. - Allergic rhinitis: diminishes nasal swelling caused by allergens.

Nesivine may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal burning or stinging sensation. - Mild headache. - Dryness of the nasal mucosa. - Sneezing. - Transient nasal irritation.

Serious or Rare Side Effects: - Persistent hypertension. - Severe nasal ulceration. - Cardiac arrhythmia. - Allergic reaction with rash or swelling. - Rebound congestion with prolonged use.

Before using Nesivine, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a clinician. - Chronic nasal disease: use only under medical supervision. - Children under 6 years: avoid unless directed by a physician. - Cardiovascular disease: monitor blood pressure if used frequently. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Oxymetazoline may interact with other agents that affect blood pressure or vascular tone.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Sympathomimetic decongestants: additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely):\n- Antihypertensive medications: possible reduction in efficacy. - Tricyclic antidepressants: may enhance vasoconstriction. - Beta‑blockers: monitor for changes in blood pressure.